Gold Nanoparticle-Enhanced Recombinase Polymerase Amplification for Rapid Visual Detection of <i>Mycobacterium tuberculosis</i>

Tuberculosis (TB) remains a major global health challenge, particularly in resource-limited settings where access to rapid and reliable diagnostics is limited. Conventional diagnostic methods, such as smear microscopy and culture, are either time-consuming or lack adequate sensitivity. This study op...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Biosensors
المؤلفون الرئيسيون: Sukanya Saikaew, Sirikwan Sangboonruang, Rodjana Pongsararuk, Prapaporn Srilohasin, Bordin Butr-Indr, Sorasak Intorasoot, Ponrut Phunpae, Chayada Sitthidet Tharinjaroen, Surachet Arunothong, Wutthichai Panyasit, Angkana Chaiprasert, Khajornsak Tragoolpua, Usanee Wattananandkul
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2025-09-01
الموضوعات:
الوصول للمادة أونلاين:https://www.mdpi.com/2079-6374/15/9/607
الوصف
الملخص:Tuberculosis (TB) remains a major global health challenge, particularly in resource-limited settings where access to rapid and reliable diagnostics is limited. Conventional diagnostic methods, such as smear microscopy and culture, are either time-consuming or lack adequate sensitivity. This study optimized recombinase polymerase amplification (RPA) using 16 primer combinations targeting IS<i>6110</i> highly specific to the <i>Mycobacterium tuberculosis</i> complex (MTC). A novel naked-eye assay, TB-GoldDx, was developed by integrating RPA combined with gold nanoparticles (AuNPs), enabling equipment-free diagnostics. TB-GoldDx demonstrated a detection limit of 0.001 ng of MTB H37Rv DNA (~210 bacilli) per 25 µL reaction. Among 100 bacterial strains, it achieved 95.83% sensitivity and 100% specificity among 100 bacterial strains, comprising 72 MTB isolates and 28 nontuberculous bacterial species. In 140 sputum samples, the assay showed 81.43% sensitivity and 58.57% specificity versus acid-fast bacilli (AFB) smear microscopy, with sensitivity improving to 95.45% in high-load AFB 3+ specimens. Compared to a commercial line probe assay (LPA), TB-GoldDx exhibited slightly higher sensitivity (84.78% vs. 82.61%) but lower specificity (54.05% vs. 78.38%). Delivering rapid, visual results in under an hour, TB-GoldDx offers a low-cost, easily deployable solution for point-of-care tuberculosis detection, especially in underserved regions, reinforcing global End TB efforts.
تدمد:2079-6374